Literature DB >> 17993737

Neuregulin-1: a potential endogenous protector in perinatal brain white matter damage.

Olaf Dammann1, Wolfgang Bueter, Alan Leviton, Pierre Gressens, Christiane E L Dammann.   

Abstract

Brain white matter damage, an important antecedent of long-term disabilities among preterm infants, has both endogenous and exogenous components. One of the endogenous components is the paucity of developmentally regulated protectors. Here we expand on this component, discussing the potential roles of one putative protector, neuregulin (NRG)-1, in brain development and damage. We outline how NRG-1 might be involved in perinatal brain damage pathomechanisms and suggest that NRG-1 might be one target for intervention. Copyright (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993737      PMCID: PMC2910616          DOI: 10.1159/000111119

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  91 in total

1.  Neuregulin-1-beta1 enters brain and spinal cord by receptor-mediated transport.

Authors:  Abba J Kastin; Victoria Akerstrom; Weihong Pan
Journal:  J Neurochem       Date:  2004-02       Impact factor: 5.372

2.  Neonatal intensive care at borderline viability--is it worth it?

Authors:  L W Doyle
Journal:  Early Hum Dev       Date:  2004-11       Impact factor: 2.079

3.  Neuregulin-1 is neuroprotective and attenuates inflammatory responses induced by ischemic stroke.

Authors:  Zhenfeng Xu; Ju Jiang; Gregory Ford; Byron D Ford
Journal:  Biochem Biophys Res Commun       Date:  2004-09-17       Impact factor: 3.575

4.  Identification of heregulin, a specific activator of p185erbB2.

Authors:  W E Holmes; M X Sliwkowski; R W Akita; W J Henzel; J Lee; J W Park; D Yansura; N Abadi; H Raab; G D Lewis
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

Review 5.  Oncostatin M: a pleiotropic cytokine in the central nervous system.

Authors:  Shao-Hua Chen; Etty N Benveniste
Journal:  Cytokine Growth Factor Rev       Date:  2004-10       Impact factor: 7.638

Review 6.  Inflammatory brain damage in preterm newborns--dry numbers, wet lab, and causal inferences.

Authors:  Olaf Dammann; Alan Leviton
Journal:  Early Hum Dev       Date:  2004-08       Impact factor: 2.079

7.  Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that induces differentiation of mammary tumor cells.

Authors:  E Peles; S S Bacus; R A Koski; H S Lu; D Wen; S G Ogden; R B Levy; Y Yarden
Journal:  Cell       Date:  1992-04-03       Impact factor: 41.582

8.  Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.

Authors:  Rose M Viscardi; Catherine K Muhumuza; Andres Rodriguez; Karen D Fairchild; Chen-Chih J Sun; George W Gross; Andrew B Campbell; P David Wilson; Lisa Hester; Jeffrey D Hasday
Journal:  Pediatr Res       Date:  2004-06       Impact factor: 3.756

Review 9.  The ErbB/HER receptor protein-tyrosine kinases and cancer.

Authors:  Robert Roskoski
Journal:  Biochem Biophys Res Commun       Date:  2004-06-18       Impact factor: 3.575

Review 10.  Neuregulin 1-erbB signaling and the molecular/cellular basis of schizophrenia.

Authors:  Gabriel Corfas; Kristine Roy; Joseph D Buxbaum
Journal:  Nat Neurosci       Date:  2004-06       Impact factor: 24.884

View more
  15 in total

Review 1.  Mechanisms of cell-cell interaction in oligodendrogenesis and remyelination after stroke.

Authors:  Kanako Itoh; Takakuni Maki; Josephine Lok; Ken Arai
Journal:  Brain Res       Date:  2015-05-08       Impact factor: 3.252

2.  Circulating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm.

Authors:  Karl C K Kuban; Robert M Joseph; Thomas M O'Shea; Timothy Heeren; Raina N Fichorova; Laurie Douglass; Hernan Jara; Jean A Frazier; Deborah Hirtz; Julie Vanier Rollins; Nigel Paneth
Journal:  J Pediatr       Date:  2016-10-24       Impact factor: 4.406

Review 3.  Extreme prematurity: Risk and resiliency.

Authors:  Genevieve L Taylor; T Michael O'Shea
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2022-02-15

4.  The ELGAN study of the brain and related disorders in extremely low gestational age newborns.

Authors:  T M O'Shea; E N Allred; O Dammann; D Hirtz; K C K Kuban; N Paneth; A Leviton
Journal:  Early Hum Dev       Date:  2009-09-17       Impact factor: 2.079

5.  Neuregulin-1, the fetal endothelium, and brain damage in preterm newborns.

Authors:  Insa Hoffmann; Wolfgang Bueter; Katja Zscheppang; Maria-Jantje Brinkhaus; Andrea Liese; Stefan Riemke; Thilo Dörk; Olaf Dammann; Christiane E L Dammann
Journal:  Brain Behav Immun       Date:  2009-09-04       Impact factor: 7.217

Review 6.  Cytokines and perinatal brain damage.

Authors:  Olaf Dammann; T Michael O'Shea
Journal:  Clin Perinatol       Date:  2008-12       Impact factor: 3.430

Review 7.  The impact of trophic and immunomodulatory factors on oligodendrocyte maturation: Potential treatments for encephalopathy of prematurity.

Authors:  Josine E G Vaes; Myrna J V Brandt; Nikki Wanders; Manon J N L Benders; Caroline G M de Theije; Pierre Gressens; Cora H Nijboer
Journal:  Glia       Date:  2020-11-30       Impact factor: 7.452

8.  Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats.

Authors:  Bingong Li; Zeqi Zheng; Yunfeng Wei; Menghong Wang; Jingtian Peng; Ting Kang; Xin Huang; Jian Xiao; Yong Li; Zhe Li
Journal:  Cardiovasc Diabetol       Date:  2011-07-29       Impact factor: 9.951

Review 9.  Inflammatory injury to the neonatal brain - what can we do?

Authors:  Noa Ofek-Shlomai; Itai Berger
Journal:  Front Pediatr       Date:  2014-04-09       Impact factor: 3.418

10.  Adult Rat Bone Marrow-Derived Stem Cells Promote Late Fetal Type II Cell Differentiation in a Co-Culture Model.

Authors:  Ab Knoll; T Brockmeyer; R Chevalier; K Zscheppang; Hc Nielsen; Ce Dammann
Journal:  Open Respir Med J       Date:  2013-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.